Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01179139 · ClinicalTrials.gov registry record · NA

Pathogenesis of Chronic Sinusitis in Relationship to Tobacco Smoke Exposure

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
97
Enrollment target

NCT01179139: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01179139 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01179139, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
97 participants
Enrollment target

Study Summary

The purpose of the study is to better understand the causes of chronic rhinosinusitis (CRS)and to determine if being around secondhand cigarette smoke causes swelling in the sinuses. To answer this question, we are inviting healthy volunteers, volunteers with chronic sinusitis, and volunteers with chronic sinusitis with nasal polyposis to complete a questionnaire and undergo a series of tests. These tests will measure their allergies, their exposure to cigarette smoke and the swelling in their sinuses. We are asking you to take part because you are in one of these groups. About 166 people will take part in this research study. All subjects will be enrolled at Massachusetts General Hospital (MGH). The Flight Attendants Medical Research Institute (FAMRI) and the Harvard Clinical and Translational Science Center Harvard Catalyst) are paying for this study.

Interventions

  • OTHER Biopsy

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2003-12
Est. Completion 2011-04
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01179139

The ClinicalTrials.gov registry entry for NCT01179139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Biopsy is the first listed.

NCT01179139 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01179139 about?

NCT01179139 is a clinical study titled "Pathogenesis of Chronic Sinusitis in Relationship to Tobacco Smoke Exposure". The purpose of the study is to better understand the causes of chronic rhinosinusitis (CRS)and to determine if being around secondhand cigarette smoke causes swelling in the sinuses. To answer this question, we are inviting healthy volunteers, volunteers with chronic sinusitis, and volunteers with c...

What is the current status of trial NCT01179139?

This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2003-12. Estimated completion is 2011-04.

What interventions are being tested in trial NCT01179139?

The interventions under investigation include: Biopsy (OTHER).

Who is sponsoring clinical trial NCT01179139?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.